An unexpected link between angiotensinogen and thrombin

FEBS Lett. 2011 Jul 21;585(14):2395-9. doi: 10.1016/j.febslet.2011.06.021. Epub 2011 Jun 25.

Abstract

Angiotensinogen is well known as source protein for a group of potent vasoactive hormones, however, a discrete biochemical activity of the angiotensinogen body is not known. Here we investigated angiotensinogen from the lamprey Lampetra fluviatilis (L. fluviatilis), an early-diverged vertebrate. The recombinantly produced protein showed progressive inhibitory activity towards human α-thrombin with a second-order rate constant of 2.6×10(4) M(-1) min(-1). Heparin enhanced the reaction rate >800-fold with a bell-shaped dose-response curve and a stoichiometry of inhibition (SI) of 1.3, revealing lamprey angiotensinogen as an effective α-thrombin inhibitor. Genomic, biochemical, and protein sequence data indicate that angiotensinogen and heparin cofactor II (HCII) originated from a common ancestral thrombin antagonist, thus providing insight into an early stage of thrombin control.

MeSH terms

  • Amino Acid Sequence
  • Angiotensinogen / genetics
  • Angiotensinogen / metabolism*
  • Animals
  • Biological Evolution
  • Humans
  • Lampreys*
  • Molecular Sequence Data
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Thrombin / genetics
  • Thrombin / metabolism*

Substances

  • Recombinant Proteins
  • Angiotensinogen
  • Thrombin